BSE filing, NSE: MARATHR. Summary written from the filing by ALFA Finder's alert engine.
Lerthai Finance Ltd: key numbers
- Share price
- ₹409.00
- Market cap
- ₹28.63 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-0.42 Cr
- P/E (TTM)
- -64.4×Sector 32.2×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 16.04%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lerthai Finance Ltd
All →Lerthai Finance Other Announcement
Lerthai Finance Ltd submitted the certificate under Regulation 74(5) from its Registrar, MUFG Intime India, confirming no demat requests were received during the quarter.
Lerthai Finance Annual General Meeting
Lerthai Finance Limited held its 47th Annual General Meeting on September 3, 2026, where shareholders approved financial statements and the re-appointment of directors.
Lerthai Finance Annual General Meeting
Lerthai Finance Limited will hold its 47th Annual General Meeting on September 3, 2026, via video conferencing. The company also released its Annual Report for FY 2025-26.
Lerthai Finance Q1 FY27 Results: Net Loss of ₹0.2 Cr, Loss Widens
Lerthai Finance Ltd reported a net loss of ₹0.2 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.2 Cr
Lerthai Finance Board Meeting Date
Lerthai Finance Limited has scheduled a board meeting for August 10, 2026. The board will consider Q1 financial results and approve the 47th AGM notice.
Lerthai Finance Capacity Expansion
Lerthai Finance Limited approved shifting its registered office to Manyata Tech Park, Bengaluru. The relocation within city limits takes effect immediately following the board's approval.
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.